Abstract P49 Table 1
AllSputum eosinophils <3%Sputum eosinophils >3%p value
Number observationsn = 165n = 114 (69%)n = 54 (31%)
Age (years)56.2 ± 13.457.4 ± 13.7553.5 ± 12.20.081
Gender
Male n (%)
Female n (%)
81 (49.1%)
84 (50.9%)
53 (46.5%)
61 (53.5%)
28 (54.9%)
23 (45.1%)
-
FEV1 (Litres)2.39 ± 0.852.46 ± 0.872.23 ± 0.790.12
FEV1% predicted80.5 ± 20.783.54 ± 19.473.7 ± 23.20.005*
FVC (Litres)3.46 ± 1.033.49 ± 1.063.36 ± 0.950.46
FVC% predicted95.1 ± 18.896.9 ± 17.591.0 ± 21.090.062
FEV1/FVC68.7 ± 9.970 ± 9.865.7 ± 9.40.008*
Body-mass index (Kg/m2) 28.6 ± 5.128.8 ± 4.026.9 ± 3.00.54
History of smoking
(Pack-years)
Median (range)
0
(0,20)
0.
(0,20)
0
(0,15)
0.87
Daily inhaled corticosteroid dose (Becolmetasone diproprionate equivalent [mcg/day])
Median (range)
400
(0, 3200)
400
(0, 3200)
800
(0, 3200)
0.05
Oral Prednisolone
Median (range)
0
(0, 20)
0
(0, 15)
0
(0, 20)
-
Juniper ACQ# score1.4 ± 1.01.1 ± 0.91.9 ± 1.2 <0.001*
Exhaled nitric oxide FeNO at 50ml flow (ppb) Geometric mean (95% CI) 25.7 (22.9, 28.8)20.0 (17.8, 22.9)44.7 (35.5, 56.23) <0.001*
Sputum differential eosinophil count %
Geometric mean (95% CI)
1.24 (0.95, 1.62)0.47 (0.39, 0.55)11.0 (8.3, 14.13) <0.001*
Blood eosinophils (x109/L)
Geometric mean
0.24 (0.22, 0.28)0.19 (0.18, 0.21)0.43 (0.36, 0.5) <0.001*
  • Arithmetic mean values reported as mean unless specified

  • ± Standard deviation

  • Geometric means are reported with a 95% Confidence Interval (CI)

  • The difference between means compared with t-test unless specified with †

  • # Juniper Asthma Control Questionnaire- A validated questionnaire providing a numerical assessment of asthma control over the preceding 7 days. The mean score ranges from 0 (fully controlled) to 6 (poorly controlled)

  • † Mann-Whitney U

  • *p < 0.05

  • FEV1- Forced expiratory volume in one second

  • FVC- Forced vital capacity

  • ppb- Parts per billion